Twist Bioscience Corp (TWST): יחס חוב לטווח ארוך להון

The price action of Twist Bioscience (TWST) reflects the development of a company that automates the creation of DNA sequences using AI-driven robots. The business is based on leadership in synthetic biology, offering affordable gene synthesis to the agro and biotech sectors. Thanks to silicon printing technologies, the firm has become a key link for laboratories, and the individual long-term debt-to-equity ratio stands at 0.18.

Diversified DNA synthesis on silicon platforms minimizes industry risks for Twist Bioscience (TWST), yet long-term debt load on capital allows for an assessment of this strategy's resilience through the ratio of liabilities exceeding one year to equity. Analysis of this metric reveals the actual dependence of business development on borrowed resources, confirming the company's ability to finance expansion without threatening its financial independence or degrading shareholder value.